US Tech 100

19,965.20

0.36%

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Vor Biopharma Inc (VOR)
Vor Biopharma Inc (VOR) News

VOR

Vor Biopharma (VOR)

Vor Biopharma Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:VOR

<< Previous 1 2 3 4 5 6

Date	Time	Source	Headline	Symbol	Company
09/09/2021	9:19AM	Dow Jones News	Vor Biopharma Gets FDA Fast-Track Designation for VOR33 for Acute Myeloid Leukemia	NASDAQ:VOR	Vor Biopharma Inc
09/09/2021	8:00AM	GlobeNewswire Inc.	VOR33 Granted U.S. FDA Fast Track Designation for AML	NASDAQ:VOR	Vor Biopharma Inc
09/02/2021	8:00AM	GlobeNewswire Inc.	Vor to Participate in Three Upcoming Investor Conferences	NASDAQ:VOR	Vor Biopharma Inc
08/19/2021	4:03PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VOR	Vor Biopharma Inc
08/09/2021	4:05PM	GlobeNewswire Inc.	Vor Reports Second Quarter 2021 Financial Results and Provides Company Update	NASDAQ:VOR	Vor Biopharma Inc
08/09/2021	4:04PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:VOR	Vor Biopharma Inc
07/09/2021	7:28AM	Dow Jones News	Vor Biopharma Working With Janssen Biotech on Leukemia Treatment	NASDAQ:VOR	Vor Biopharma Inc
07/08/2021	8:00AM	GlobeNewswire Inc.	Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined With a ...	NASDAQ:VOR	Vor Biopharma Inc
06/17/2021	8:14AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VOR	Vor Biopharma Inc
06/17/2021	8:00AM	GlobeNewswire Inc.	Vor to Build-Out State-of-the-Art Clinical Manufacturing Facility Capable of Supporting Multiple Cell Therapy Programs	NASDAQ:VOR	Vor Biopharma Inc
06/11/2021	8:00AM	GlobeNewswire Inc.	Vor Biopharma Names Matthew R. Patterson as Chairman and Promotes Tania Philipp	NASDAQ:VOR	Vor Biopharma Inc
06/10/2021	8:00AM	GlobeNewswire Inc.	Vor to Develop Multi-Targeted CAR-Ts with Abound Bio	NASDAQ:VOR	Vor Biopharma Inc
05/25/2021	4:10PM	GlobeNewswire Inc.	Vor Biopharma to Present at Jefferies and Goldman Sachs Investor Conferences	NASDAQ:VOR	Vor Biopharma Inc
05/06/2021	4:08PM	GlobeNewswire Inc.	Vor Reports First Quarter 2021 Financial Results and Provides Company Update	NASDAQ:VOR	Vor Biopharma Inc
05/06/2021	4:04PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:VOR	Vor Biopharma Inc
04/28/2021	8:00AM	GlobeNewswire Inc.	Vor To Present on VOR33 Manufacturing Scale-Up and Off-Target Editing at ASGCT	NASDAQ:VOR	Vor Biopharma Inc
04/05/2021	4:34PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VOR	Vor Biopharma Inc
03/25/2021	4:35PM	GlobeNewswire Inc.	Vor Reports Fiscal Year 2020 Financial Results	NASDAQ:VOR	Vor Biopharma Inc
03/10/2021	9:47AM	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:VOR	Vor Biopharma Inc
03/05/2021	3:00PM	GlobeNewswire Inc.	Vor Biopharma to Present at the Barclays Global Healthcare Conference	NASDAQ:VOR	Vor Biopharma Inc
03/05/2021	10:25AM	Edgar (US Regulatory)	Sec Staff Action/letter (sec Staff)	NASDAQ:VOR	Vor Biopharma Inc
03/05/2021	10:25AM	Edgar (US Regulatory)	Sec Staff Action/letter (sec Staff)	NASDAQ:VOR	Vor Biopharma Inc
03/01/2021	3:45PM	GlobeNewswire Inc.	Vor Biopharma Announces Participation at Cowen 41st Annual Health Care Conference	NASDAQ:VOR	Vor Biopharma Inc
02/19/2021	4:36PM	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:VOR	Vor Biopharma Inc
02/19/2021	4:31PM	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:VOR	Vor Biopharma Inc
02/09/2021	4:05PM	GlobeNewswire Inc.	Vor Biopharma Closes Over $200M Initial Public Offering, Including Full Exercise of Option to Purchase Additional Shares	NASDAQ:VOR	Vor Biopharma Inc
02/05/2021	6:50AM	Business Wire	PureTech Founded Entity Vor Biopharma Announces Pricing of Initial Public Offering	NASDAQ:VOR	Vor Biopharma Inc
02/05/2021	6:33AM	GlobeNewswire Inc.	Vor Biopharma Announces Pricing of Initial Public Offering	NASDAQ:VOR	Vor Biopharma Inc